Bone Graft Substitutes Containing Recombinant Proteins or Synthetic Peptides in Patients Under Age 18: FDA Safety Communication - Reports of Serious Injuries

Risk of excess bone growth, fluid accumulation, inhibited bone healing, and swelling.